marijuana stock news

Tauriga Sciences, Inc. (TAUG)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 29   11   –   –  
Cost of Revenue 9 3
Gross Profit 20   8   –   –  
Operating Expenses
Research Development
Selling General and Administrative 717 1,054 1,793 1,681
Non Recurring 1,356
Others 30 30 30 63
Total Operating Expenses
Operating Income or Loss (728) (1,535) (1,365) (3,101)
Income from Continuing Operations
Total Other Income/Expenses Net (600) (712) 343 (1,845)
Earnings Before Interest And Taxes (1,327) (1,788) (1,480) (4,946)
Interest Expense 58 31 95 276
Income Before Tax (1,385) (1,820) (1,576) (5,221)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (1,385) (1,820) (1,576) (5,221)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,385) (1,820) (1,576) (5,221)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,385) (1,820) (1,576) (5,221)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

 Wayland Group Corp. (MRRCF) Announces Court Approval of Sale Process

Wayland Announces Court Approval of Sale Process  Wayland Group Corp. (CSE:WAYL) (“Wayland”…

Jushi Holdings Inc. (JUSHF) to Participate in the ATB Capital Markets 10th Annual Institutional Investor Conference

Jushi Holdings Inc. to Participate in the ATB Capital Markets 10th Annual…

INSYS Therapeutics, Inc. (INSY) Announces Participation at FDA Advisory Committee Meeting

INSYS Therapeutics Announces Participation at FDA Advisory Committee Meeting Addressing the Co-Prescribing…